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Abstract
Background: Monocytes and macrophages play essential role in innate immunity. Understanding
the underlying mechanism of macrophage differentiation and the identification of regulatory
mechanisms will help to find new strategies to prevent their harmful effects in chronic inflammatory
diseases and sepsis.
Results: Maturation of blood monocytes into tissue macrophages and subsequent inflammatory
response was mimicked in U937 cells of human histocytic lymphoma origin. Whole genome array
analysis was employed to evaluate gene expression profile to identify underlying transcriptional
networks implicated during the processes of differentiation and inflammation. In addition to already
known transcription factors (i.e. MAFB, EGR, IRF, BCL6, NFkB, AP1, Nur77), gene expression
analysis further revealed novel genes (i.e. MEF2, BRI, HLX, HDAC5, H2AV, TCF7L2, NFIL3)
previously uncharacterized to be involved in the differentiation process. A total of 58 selected
genes representing cytokines, chemokines, surface antigens, signaling molecules and transcription
factors were validated by real time PCR and compared to primary monocyte-derived macrophages.
Beside the verification of several new genes, the comparison reveals individual heterogeneity of
blood donors.
Conclusion: Up regulation of MEF2 family, HDACs, and H2AV during cell differentiation and
inflammation sheds new lights onto regulation events on transcriptional and epigenetic level
controlling these processes. Data generated will serve as a source for further investigation of
macrophages differentiation pathways and related biological responses.
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The mammalian innate immune system, comprised of
macrophages, provides a front line of defense against
pathogens. Infection or dysfunction of macrophages
results in clinical situations like septic shock or chronic
inflammatory disease such as atherosclerosis and rheuma-
toid arthritis. Under normal steady-state conditions,
monocytes migrate randomly from blood to various
organs or body cavities and differentiate into macro-
phages through coordinate expression of numerous
genes. During a local infection, migration of blood mono-
cytes into the inflamed tissues is accelerated, and subse-
quent differentiation into macrophage occurs rapidly [1].
Upon the entry of microorganisms, conserved structures
found in a broad range of pathogens are recognized by
toll-like receptors (TLRs) of macrophages. Phagocytic
macrophages are activated to produce inflammatory
cytokines (i.e. TNFalpha) and chemokines (i.e. IP10). Sig-
naling pathways triggered by individual TLRs involve
recruitment of adaptor molecules (i.e. MyD88) and auto-
crine production of IFNbeta. Two distinct cascades,
MyD88 dependent and MyD88 independent (IFNbeta
mediated), lead to activation of immuno-regulatory tran-
scription factors (i.e. IRFs, STATs, NFkB, AP1) to modulate
inflammatory gene expression [2].
Transcriptional regulators play important roles during
developmental processes, and were described in a variety
of well-studied differentiation systems. During the proc-
ess of hematopoietic differentiation of monocytes, func-
tions of transcription factors encompass up regulation of
genes specific to the lineage and repression of lineage-
inappropriate genes by forming distinct protein com-
plexes [56]. Similarly, cell-type-specific gene expression
during macrophage differentiation and function is a result
of complex transcriptional regulation by the interplay
between endogenous transcription factors and external
signals, and also by the networks of individual transcrip-
tion factors. Whatever other mechanisms can modulate
their activity, expression of specific transcription factors
during differentiation process is likely to be regulated
transcriptionally. Several transcription factors including
MAFB, EGRs, NFkB, AP1, IRFs and BCL6 that control var-
ious stages of macrophage development or function have
already been identified [4,5]. However, only a genome-
wide expression study will be able to identify all transcrip-
tional regulators, gene regulatory networks and help to
understand molecular mechanisms underlying relevant
immune disease.
Furthermore, the role of chromatin structure in gene reg-
ulation of immune system has been increasingly studied.
In activated macrophages stimulated by LPS, the tran-
scriptional response has been attributed to the expression
and function of chromatin remodeling genes, mainly
related to histone modifications [6-8]. Timely coordi-
nated relationship regarding transition of chromatin
structure, nucleosome remodeling and transcription fac-
tors are known to be important [9]. Under such a circum-
stance, it is of utmost importance to study genome-wide
gene expression changes in model systems that make it
feasible to continue investigating and dissecting underly-
ing molecular mechanisms.
The use of a model system circumvents many problems
including available cell numbers, high cost and tedious
procedure, generally encountered while having to work
with primary blood cells. However, the validity of any sin-
gle myeloid model system has never been fully verified.
Among several myeloid cell lines (HL60, THP-1, Monon-
omac-1, U937), U937 cells and THP1 cells are the most
widely used models for investigating monocytic differen-
tiation and subsequent biological functions of differenti-
ated cells [10,11]. In contrast to THP-1 cells at less mature
stage due to their blood leukemic origin, U937 cells of his-
tocytic lymphoma origin are arrested in a more advanced
stage of differentiation (promonocyte/monocyte). Vari-
ous stimuli (i.e. DMSO, Retinoic acid, VitD3, PMA, IFN-
gamma), either alone or in combination, have been
attributed to induce their terminal differentiation into
monocytes or mature macrophages. Upon differentiation,
U937 cells acquire a large repertoire of macrophage func-
tion through the concerted expression of numerous genes.
Differentiated U937 cells can be further stimulated with
LPS (E. coli Lipopolysaccharide) to mimic inflammatory
response of activated macrophages.
In this study, we employed the U937 model system com-
bined with a cRNA hybridization-based whole genome
array to analyze genome-wide expression patterns during
monocyte-macrophage differentiation and LPS-respon-
sive activation of differentiated cells. The identification of
novel transcriptional regulators intensifies directions for
further investigation of the molecular mechanism involv-
ing common regulatory networks and epigenetic mecha-
nisms.
Results
U937 cells were differentiated into monocyte and 
macrophage-like cells
U937 cells have been widely used as a model to investi-
gate a variety of biological processes related to monocyte
and macrophage function. Here, we used either the hor-
monally active form of Vitamin D3 (1, 25-dihydroxyvita-
min D3) to differentiate U937 cells toward monocytes, or
PMA (phorbol 12-myristate 13-acetate) to induce differ-
entiation into a macrophage-like phenotype. Both PMA
and VitD3 were known to induce cell cycle arrest prior to
proceeding into differentiation stage. PMA-treated cells
exhibit apparent growth arrest already 6 hrs after the addi-
tion of PMA and almost 100% adherence of cells after 24
hrs. Cells then tend to loose adhesiveness gradually after-Page 2 of 15
(page number not for citation purposes)
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with VitD3-treated cells that continued moderate prolifer-
ation even after addition of the reagent (data not shown).
Cells differentiated for 24 hrs by each inducer were used
for further analysis and LPS stimulation.
Fluorescence activated cell-sorting (FACS) was carried out
to monitor two surface proteins characteristic of differen-
tiated U937 cells (data not shown): (1) CD14, serving as
a marker for both monocyte and macrophage, is involved
in LPS recognition and facilitating LPS contact with TLR4
receptor; (2) CD11b, serving as a macrophage marker, is
involved in phagocytosis of bacteria. CD14 expression
was increased after VitD3 differentiation, yielding the
characteristics of monocyte-like cell type. This result is
also in accordance with mRNA expression, and is certainly
indicative of enhanced sensitivity of these cells to LPS
stimulation [12]. CD11b expression was increased only
after PMA inducement, indicating macrophage-like differ-
entiation, meanwhile no CD14 induction was observed
with these cells.
According to well-known molecular mechanisms under-
lying macrophage activation, TNFalpha is a gene product
of MyD88-dependent pathway (common to both mono-
cytes and macrophages) while IFNbeta is an autocrine
product destined to launch MyD88-independent pathway
specific for macrophages [2]. In the case of sepsis, persist-
ing and systemic release of TNFalpha by activated macro-
phages can cause organ failure and death as a result of
septic shock. Inevitably, it would require tight regulation.
In order to demonstrate successful differentiation leading
to activated macrophages, mRNA accumulation of TNFal-
pha and IFNbeta was analyzed by real-time PCR. The
result from stimulation of PMA and VitD3 differentiated
cells with 10 μg/ml LPS is shown in Figure 1. Immediate
expression (2 hrs) of TNFalpha was common to all sam-
ples (control, VitD3, PMA). With control U937 cells and
VitD3-differentiated cells, decreasing production of
TNFalpha mRNA was observed across the later period of
stimulation (12 ~22 hrs). PMA differentiated cells shows
a dramatically decreased TNFalpha expression after 12 hrs
but increased again at 22 hrs. This distinct biphasic behav-
ior is a manifestation that macrophage-like cells possess
an intrinsic 'automatic-bridle' system to modulate pro-
duction of this cytokine in a time dependent manner.
Stimulation at the lower concentration of LPS (2 μg/ml)
showed the same pattern except that the biphasic behav-
ior was extended up to 48 hours. Time dependent mRNA
accumulation of IFNbeta was also characteristic for PMA
differentiated cells representative of macrophages. Ini-
tially, a moderate increase of mRNA was observed (at 2
hrs). Afterwards, further increase was prominently
induced (10 hrs). By the time of 22 hrs, the mRNA level
was maintained at the level comparable to initial stage.
On the contrary, control U937 cells and VitD3 differenti-
ated cells manifest much less prominent accumulation of
IFNbeta after both 2 and 10 hrs, and are completely
devoid of it by the time of 22 hrs. It indicates that these
cells are inefficient (during earlier period) and finally
lacking (during later period) in IFNbeta induced MyD88-
independent pathway.
Differential gene expression of U937 cells manifests 
functional macrophage phenotype
Whole transcriptome expression profiling was performed
with two biological replicates and two technical replicates
from each of seven different samples (control, PMA 6 hrs,
PMA 12 hrs, PMA 24 hrs, PMA 32 hrs, LPS, VitD3) while sat-
isfying each set of replicates on separate slides. To evaluate
the consistency of data across biological or technical repli-
cates, correlation coefficients were calculated. In all cases, the
correlation between biological replicates and also technical
replicates were higher than 0.98 (see Additional file 1). Dur-
ing PMA differentiation, there was a shift of correlation coef-
Differential mRNA accumulation of TNFalpha and IFNbetaFigu  1
Differential mRNA accumulation of TNFalpha and 
IFNbeta. Only PMA differentiated cells, representatives of 
macrophages, exhibit distinct biphasic behavior of TNFalpha 
accumulation (2 and 22 hrs) and time dependent up regula-
tion (10 hrs and 22 hrs) of IFNbeta. Error bars refer to tech-
nical variation. Relative expressions were represented as log 
RQ (base 2) in which RQ (relative quantification) = 2-ddCt. 
Different duration of LPS stimulation was indicated by white 
bar (2 hrs), black bar (10 hrs for IFNbeta, 12 hrs for TNFal-
pha) and gray bar (22 hrs) on the graph.
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indicating 3.9% to 8.1% of gene features contained on the
array were differentially regulated. There appeared only 0.6%
(0.925 ~0.919) of change between 24 hrs and 32 hrs of PMA
differentiation. This shows that the cells were already
reached a state of full differentiation after 24 hrs. It is note-
worthy that additional 3.8% of features were promptly
induced within 2 hrs of subsequent LPS stimulation.
Gene expression of differentiated or stimulated cells was
evaluated in comparison to undifferentiated U937 cells.
Differential gene expression was considered 'significant'
when the normalized intensity ratio of sample vs control
was >1.9 (up) or <-2 (down), respectively (Figure 2A–D).
At 6 hrs of PMA differentiation, 324 genes were up regu-
lated and 169 genes down regulated. After 12 hrs, 337
genes were additionally up regulated while 126 genes
were down regulated. By the time of 24 hrs, total 595
genes were up regulated and 324 genes down regulated.
After 2 hrs of subsequent LPS stimulation, 278 additional
genes were up regulated while 107 additional genes were
down regulated. With VitD3 differentiation, only 35 genes
were significantly up regulated while 15 genes down reg-
ulated. The complete list of gene expression profiling is
available in Additional file 2.
Top 50 most highly up regulated genes, sorted by 24 hrs
of PMA differentiation, are shown in Table 1. Among
them are several genes well known to be related with dif-
ferentiation process as well as monocyte and macrophage
functions. This involves proteins known to be involved in
the differentiation process (CDK inhibitor p21), cytokine
transporter like A2M, chemokines like CCL3 and IP10 as
well as matrix metalloproteinase protein such as MMP7
and MMP9 involved in the proteolysis of structural and
adhesive matrixes.
Temporal pattern of array gene expression can be 
categorized
Large scale comparisons of differential gene expression pro-
files between different experimental conditions (for exam-
ple, different time points of differentiation and activation)
have potential to identify co-regulated and/or inter-related
genes. Such categories reflect their functional relationships
and can help to identify common transcriptional control
mechanisms. Transcription factors in such groups of genes
may be responsible for regulation of the genes in the same
group. Beside genes not affected, three distinct groups
could be categorized. Nine examples of time dependent
gene expression were illustrated in Figure 3. IL6 (cytokine),
CXCL2 (chemokine) and Nur77 (transcription factor) rep-
resent a group of genes that are highly up regulated only
after LPS-responsive activation. NCF1, A2M, MMP9, all of
which related to macrophage function, and transcription
factor MEF2A represent a second group of genes whose
expression was constantly up regulated during differentia-
tion period and also activation. CTSG and TNFSF13B, rep-
resent a third group of genes specifically down regulated
during macrophage differentiation. Both proteins are
related to functions in neutrophils and B cells respectively.
Validity of expression analysis was verified by real timePCR
Among 58 selected genes validated by real time PCR
(Table 2), were cytokines and chemokines (TNFalpha,
IL1A, IL1B, IL6, IL8, CCL3, CCL4, CXCL2, IP10), inflam-
matory effector molecules (MMP7, MMP9, PLAU, C3,
A2M, NCF1, LAMB3, LL37, CD38), surface antigens
(CD11b, CD14, CD69, CD83), signaling molecules
(MyD88, TLR2, SGK, JAK3) and transcription factors.
The fold change of greater than 20 from the array corre-
spond to a factor of greater than 100 RQ fold (relative
quantification, in which RQ = 2-ddCt) based on real time
PCR (>ddCt -7). Likewise, array fold change between 10
and 20 usually fell within the range of 10 to 50 RQ fold
while low fold change around 2 or 3 were equal to various
range from less than 5 up to 30 RQ fold. Taking an exam-
ple of LPS stimulated sample, confirmation rate of up or
down regulation by real time PCR result was 100%. With
PMA samples, a few cases of inconsistency, as with IL8,
IL1A and CCL4, were observed
Identification of transcriptional regulators
Transcriptional regulators already known to be involved
in monocytic-lineage differentiation (i.e. EGR1, EGR2
Gene expression profileFigur  2
Gene expression profile. Shown are numbers of up regu-
lated (A) and down regulated (B) genes after PMA, VitD3 dif-
ferentiation and LPS stimulation (2 hrs). Numbers of 
differentially regulated genes at different time points (6, 12, 
24 hrs) during PMA differentiation are shown in C (for up 
regulation) and D (for down regulation).
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Table 1: List of top 50 up regulated genes (sorted by PMA 24 hrs)
Illumina array fold change
Ref.Seq. Gene Symbol PMA6 PMA12 PMA24 PMA32 LPS VitD3
NM_014220 HL6 20.6 88.5 96.3 96.5 128.2 1.1
NM_005368 MB 4.3 27.8 90.5 110.5 96.2 7.7
NM_000582 BNSP 7.6 31.1 84.1 118.1 110.9 1
NM_021796 PLAC1 1.8 11.8 34.6 39.1 34.3 -1.1
NM_002423 MMP7 1.9 2.7 29.9 61.4 36.5 -1.4
NM_002922 RGS1 15.9 25.6 28.6 26 29.9 -1.1
NM_018993 RIN2 9.5 18.2 23.2 18.9 14.4 1
NM_001955 EDN1 42.9 22.9 21.2 22.9 85.4 1
NM_000265 NCF1 3.4 11.2 18.6 21 17.8 3.8
NM_001332 CTNND2 1.5 4.9 15.7 20.4 12.8 1.1
NM_016270 KLF2 15.5 11.6 13.9 15.2 9.8 -1.3
NM_002167 ID3 1.8 3.4 11.9 6.2 38.9 2.7
NM_002203 CD49B 2 7 10.5 9.3 6.9 1
NM_000014 A2M 4.1 7.4 10.4 11.1 11.5 1.1
NM_001401 EDG2 4.4 9.2 10.3 8.8 6.6 -1.8
NM_152591 CCDC63 2.5 7.1 9.9 9.8 10.6 -1.1
NM_030820 COL20A1 1.2 2.8 8.8 7.7 7.4 -1.1
NM_004994 MMP9 2.4 6 8.4 10.1 8.3 -1.2
NM_004926 BERG36 6.5 8.1 8.2 7.7 9.9 -1.4
NM_001200 BMP2 15.2 13.6 8.1 4.1 10.3 -1.2
NM_015271 RNF86 2.6 5.5 8.1 10 7 -1
NM_021952 ELAVL4 7.3 8.1 8 7.9 6.8 -1.1
NM_001706 BCL6 7.1 8.3 7.6 7.6 19.5 1.6
NM_001565 CXCL10 1.4 1.5 7.5 12.6 23.4 -1
NM_005627 SGK 3.4 4.9 7.5 6.6 13 -1
NM_007351 ECM 3.3 7.2 7.3 8.4 8 1.1
NM_206827 RASL11A 1.2 4.3 7.2 6 4.5 1.2
NM_002983 CCL3 8.9 8.9 7.1 8.2 197.3 1.4
NM_003294 ALPHAII 2.4 4.6 7.1 9.4 8.6 1.1
NM_153370 PI16 1 1.6 6.9 10.3 6.9 1
NM_003986 BBH 1.7 3 6.8 9.8 6.6 -1.2
NM_025113 C13ORF18 2.5 4.7 6.7 5.3 14.8 1.3
NM_005449 TOSO 3.7 8.4 6.4 6 7 1.4
NM_000389 P21 2.4 4.2 6.1 6.1 11.8 1.3
NM_001001437 CCL3L3 8.5 7.8 6 6.1 187 1.2
NM_001268 CHC1L 1.6 3.4 6 6.8 4.7 1.1
NM_206939 CD20L4 -1.2 2.8 5.9 8.3 6.9 -2
NM_004615 A15 1.2 3.5 5.8 6.3 4.8 -1.3
NM_016134 PGCP 1.4 3 5.7 7.1 5.4 -1.1
NM_005211 CD115 2.2 5.6 5.6 4.8 5.1 1.7
NM_147130 LY117 2.8 5.3 5.6 4.5 5.3 1.2
NM_013445 GAD 1.1 3.9 5.6 5.9 5 -1.2
NM_007079 PRL3 1.6 3.9 5.6 7.9 7.1 -1.2
NM_032199 ARID5B 7 5 5.5 5.7 6.6 -2.1
NM_001257 CDH13 1 2.7 5.5 5.6 5.1 -1.2
NM_001017998 GNG10 2 4.3 5.5 7.4 5.3 1.5
NM_005842 HSPRY2 4.3 5.8 5.4 5.2 4.1 -1
NM_016257 HLP4 1.2 2.7 5.4 7 5.3 1.2
NM_052815 DIF2 6.8 5.1 5.3 4.7 157.7 1.1
NM_014862 ARNT2 2.5 5.4 5.3 4.8 5.3 -1
The column designation indicates different time points of differentiation with PMA (6 hrs, 12 hrs, 24 hrs and 32 hrs), VitD3 (24 hrs) and subsequent 
activation of PMA differentiated cells (24 hrs) by LPS (2 hrs). The numbers denote fold change after normalization of Illumina array data. The order 
of genes was sorted by PMA 24 hrs sample in descendent manner.
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entiation process and subsequent activation (see Addi-
tional file 3). Previously unknown factors (i.e. BRI, HLX1,
TCF7L2, MEF2 family) were also shown to be significantly
and constantly up regulated. Of the most interesting new
identified transcription factors are proteins belonging to
the MEF2 (myocyte enhancer factor 2) family. Moreover,
a target gene (i.e. Nur77) of MEF2 during T cell apoptosis
and postsynaptic differentiation were also up regulated.
This is in line with previous reports [13-15]. Among the
population of transacting proteins identified, several fac-
tors acting as transcriptional repressors (ID3, BCL6,
NFIL3) and histone modifying proteins (HDAC5,
HDAC7/9) were verified. Histone deacetylases (HDACs)
were previously implicated as key molecules to repress
production of pro-inflammatory gene expression, thus
prevent excessive inflammatory responses [16]. KLF2 and
KLF4 have been recently described as critical regulators
controlling monocyte differentiation and proinflamma-
tory activation [17,18]. Both factors are validated to be up
regulated by real time PCR (Table 2). This together with
up regulation of KLF6 suggests importance of kruppel-like
family of transcription factors (KLFs) in the differentia-
tion and function of macrophages. Upon LPS stimulation,
NUR77, FOS, JUN, STAT3, IRF family, NFkB family and
SMAD family show significant up regulation, thus con-
firm their classical role in macrophage function of inflam-
matory response. One of the main physiological roles of
NFkB family is in the development and functioning of the
immune system by regulating transcription of cytokines
and antimicrobial effectors as well as genes that regulate
cellular differentiation, survival and proliferation [19].
Consistently, RELB, cREL, NFkB1 and NFkB2 are signifi-
cantly induced upon LPS stimulation, thus confirming the
validity of U937 model system.
Cross validation between U937 cells and primary blood 
monocytes
Various macrophage populations from different tissues of
the body exhibit different morphological and functional
phenotypes. Two cytokines, macrophage colony-stimulat-
ing factor (M-CSF) and granulocyte-macrophage colony-
stimulating factor (GM-CSF), are known to promote dif-
ferentiation of monocytes into macrophages with distinct
phenotypes existing in vivo. It is known that M-CSF differ-
entiated macrophages are very similar to peritoneal mac-
rophages [20,21]. As a counterpart of PMA-differentiated
U937 cells, M-CSF differentiated macrophages were gen-
erated from primary blood monocytes, and further acti-
vated with LPS (see materials and methods). Real time
PCR shows that both CD14 and CD11b were up regulated
with M-CSF differentiated macrophages (Figure 4). Addi-
tionally, monocyte-derived macrophages manifest down
regulation of TNFalpha in contrast to PMA-differentiated
U937 cells where up regulation was shown.
Expression data of 24 top regulated transcriptional regula-
tors from U937 cells including activators, repressors, his-
tone modifying enzymes and histone variants were
subjected to cross validation in comparison to primary
human monocytes derived macrophages (M-CSF/macro-
phages). Two distinct groups of genes could be identified
(Table 3). Within the first group, 54.2% (n = 13) of the
genes (MEF2 family, HLX1, BRI, HDAC5, H2AV, BCL6,
EGR1, ID3, IRF9, FOS, Nur77) were differentially
expressed during differentiation and/or activation in both
U937 cells and primary M-CSF/macrophages. Interest-
ingly, both cell types manifest moderate up regulation (2
~4 RQ fold) of H2AV. The expression consistency of
BCL6, EGR1 and FOS depended upon the stage of cells
(either differentiated or activated). Despite the generally
known concept that Nur77 is induced only after LPS stim-
ulation, one individual donor manifest up regulation
already upon macrophage differentiation. Nevertheless,
these factors are most likely to be true regulators in the dif-
ferentiation and function of monocytic cells. A second
group of genes (TCF7L2, HDAC7, EGR2, KLF2, KLF4,
FOXA2, OCT2, HES1, PCAF, IRF7, MEF2B) showed a very
opposite or no differential gene expression (45.8%; n =
11). Among these factors, TCF7L2 is noteworthy. It is a
ubiquitous transcription factor in Wnt signaling pathway,
but has not been connected to any immune cell gene tran-
scription up to date.
Cellular localization of transcription factors
As a step toward verifying actual involvement of selected
transcription factors in activating gene program, protein
Temporal patterns of gene expressionFigure 3
Temporal patterns of gene expression. Shown are 
examples of three distinct groups: outstanding up regulation 
upon LPS stimulation (IL6, CXCL2, Nur77), constant up reg-
ulation (NCF1, A2M, MMP9, MEF2), and constant down reg-
ulation (CTSG and TNFSF13B) during macrophage 
differentiation period.
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Illumina array fold change Real time PCR
Ct RQ fold *
Ref.Seq Gene Symbol PMA24 LPS VitD3 Cont PMA24 LPS VitD3
Cytokines and Chemokines
NM_002983 CCL3 7.1 197.3 1.4 26 27.9 776 1.6
NM_000594 TNFa 3 121.4 1.6 29 13.9 119.4 1.1
NM_000584 IL8 3.7 82.9 2.3 25 1.2 222.9 3.2
NM_000575 IL1A 1.1 98.7 -1 35 5.7 2195 2.3
NM_000576 IL1B 2.9 75.2 1.1 26 2.5 415.9 0.7
NM_004591 CCL20 -1 47.6 1.1 30 2.1 724.1 0.9
NM_000600 IL6 3.7 29.9 2.1 28 4.6 157.6 3.5
NM_001565 IP10 7.5 23.4 -1 30 97 222.9 0.7
NM_002089 CXCL2 1.2 16.5 1.1 28 0.4 48.5 1.7
NM_002984 CCL4 1.1 1.7 1.1 35 52 80,000 1.9
Surface molecules
NM_004233 CD83 1.8 10.4 -1.1 23 3.2 9.8 0.6
NM_001781 CD69 1.4 4.1 -1.4 21 3.2 4.9 0.9
NM_000632 CD11b 3.3 3.1 2.7 24 7.5 3 2.6
NM_000591 CD14 -1 1.2 22.4 29 1.1 1.1 45.3
Signaling and effector molecules
NM_002423 MMP7 29.9 36.5 -1.4 28 512 181 0.6
NM_002658 PLAU 1.3 19.9 -1 28 1.1 5.3 0.6
NM_000265 NCF1 18.6 17.8 3.8 29 32 39.4 2.6
NM_005627 SGK 7.5 13 -1 22 10.6 52 1.6
NM_000389 p21 6.1 11.8 1.3 25 42.2 42.2 1.1
NM_000014 A2M 10.4 11.5 1.1 30 52 32 3.2
NM_004994 MMP9 8.4 8.3 -1.2 30 21.1 9.2 1.1
NM_000228 LAMB3 2.9 6.5 8.5 28 32 19.7 64
NM_002468 MYD88 4.5 4.2 1.4 27 27.9 7.5 1.5
NM_000064 C3 1.8 2.3 -1 27 119.4 42.2 1.2
NM_003264 TLR2 1.4 1.6 1.1 31 11.3 3.2 2
NM_000215 JAK3 1.5 1.7 1.1 18 5.7 4.9 1.4
NM_004345 LL37 -1.2 -1.3 32.1 30 1.3 0.8 84.4
NM_001775 CD38 -1.9 -2 5.9 22 1.1 0.2 7.5
NM_001911 CTSG -3.4 -4.8 -1.3 21 0.03 0.01 0.6
NM_006573 TNFSF13B -4.3 -5.1 -1.2 22 0.3 0.1 1.9
NM_000250 MPO -8.3 -9.6 -1.1 17 0.1 0.03 1.1
Transcription factors/Histone modifiers
NM_005384 NFIL3 3.1 4.9 -1.3 27 9.8 78.8 3.2
NM_000321 RB1 2.2 1.8 1 19 3 1.1 -0.2
NM_005461 MAFB 3.3 35.8 1.2 27 17.1 18.4 -1.1
NM_005587 MEF2A 4 4.4 1.1 19 9.2 4.3 1.1
NM_002397 MEF2C 1.8 1.9 -1.2 19 8 4.3 1.6
NM_005920 MEF2D 2.1 7.9 -1.1 26 1.1 3 0.5
NM_021958 HLX1 2.2 2.3 -1 23 10.6 3.5 1.2
NM_021999 BRI 2.6 2.2 -1.2 22 8.6 3.7 1.2
NM_005474 HDAC5 NA 24 4.9 4 0.8
NM_012412 H2AV NA 19 2.6 1 1.3
NM_173158 Nur77 1.2 11.7 1.1 35 1.1 2.3 1
NM_001706 BCL6 7.6 19.5 1.6 25 78.8 34.3 8
NM_001964 EGR1 4.2 13.6 1.1 27 14.9 1.2 1.4
NM_005252 FOS 2.4 3.3 -1.5 26 32 2.6 0.9
NM_002167 ID3 11.9 38.9 2.7 30 13 18.4 8
NM_006084 IRF9 2.5 2.8 1 25 214.5 5.3 1.4
NM_000399 EGR2 5.3 27.3 1.1 28 5.3 4.3 2.5
NM_016270 KLF2 13.9 9.8 -1.3 26 32 97 0.5
NM_021784 FOXA2 4.9 2.9 -1 30 73.5 16 0.3
NM_005524 HES1 2.8 2.8 1.2 32 27.9 64 0.8Page 7 of 15
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nucleic fraction by western blot. In order to probe 15 pro-
teins among top regulated transcription factors, twenty dif-
ferent antibodies were tested by ELISA and western blot.
Western Blot could detect proteins in cytosolic and nuclear
fraction with a clear tendency toward nucleic fraction.
Three antibodies were determined to meet the criteria
(showing one specific band) that allow their use for protein
quantification. Figure 5 shows the results of western blot
with these three antibodies. MEF2 antibody recognizes
three members (MEF2A, 2C and 2D) simultaneously. One
specific band of about 55 kDa in size (white bar in Figure
5, corresponding to the size of MEF2A) was detected in
cytosolic fraction while two bands of similar size and inten-
sity (~50 kDa and ~60 kDa, corresponding to MEF2C and
2D) were detected in nucleic fraction (black bar in Fig. 5
represent upper size of ~60 kDa). While expression of
cytosolic proteins appears to be decreased, nucleic proteins
show 3 ~4 fold induction during macrophage differentia-
tion and subsequent activation by LPS. Up regulation of
proteins were comparable to mRNA induction of 3 ~9 RQ
fold (ddCt value -1.6 ~-3.2, Table 2). Both NFkB1/p50 and
TCF7L2 antibodies produced specific bands with nucleic
fractions only. Corresponding to mRNA expression of 5.3
RQ fold (ddCt value -2.4 for LPS sample) and 8.6 RQ fold
(ddCt value -3.1 for PMA sample), protein expression of
TCF7L2 was clearly induced (up to 5 fold for PMA sample)
while LPS sample shows moderate induction of less than 2
fold. Prominent induction of NFkB1/p50 protein after LPS
stimulation is also in line with its classical role during
inflammatory responses. With all antibodies tested by
ELISA, fluorescence detection of antibody binding to pro-
tein substrate was observable only with nucleic fraction
(data not shown).
Discussion
U937 cells as valid model system
The relatively small number of genes up and down regulated
after VitD3 differentiation is a strong indication that U937
cells used in this study are nearly proximal to functional
monocytes (Figure 2). Despite both CD14 and CD11b are
induced in monocyte-derived macrophages, U937 cells-
derived macrophages manifest up regulation of CD11b
alone (Table 2 and Figure 4). However, lack of CD14 induc-
tion should not impair the essential function representing
macrophages. CD14 binds LPS to facilitate recognition by
TLR4, but does not participate directly in signaling. TLR4
alone can function as a singular signaling receptor for LPS.
Moreover, LPS signaling in U937 cells can bypass the neces-
sity of CD14 component of receptor complex due to high
concentration of LPS (2 μg/ml or 10 μg/ml) used in this
study. The abundance of TNFalpha mRNA prior to differen-
tiation was higher with primary monocytes (data not
shown) when compared to U937 cells as manifested by ini-
tial Ct value. Taken together, the lack of CD14 expression
and the induction of TNFalpha in PMA-differentiated U937
cells can be attributed to the effect of the artificial differenti-
ation system. The MyD88-independent pathway is responsi-
ble for sustenance of the proinflammatory program with
delayed kinetics of NFkB activation, in the meantime the
MyD88-dependent pathway triggers response to initial chal-
lenge [22,23]. It is likely that the biphasic behavior of TNFal-
pha production (up regulation at early and late time points)
observed with macrophage-like cells (Figure 1) reflects cross
talks and temporal segregation between these two pathways.
Up regulation of RB together with p21 upon PMA differenti-
ation is in line with proliferation arrest prior to differentia-
tion process of cells. Both JAK3 and STAT3 (Additional file 3)
are known to play a vital role in monocytic differentiation
[24,25]. JAK3 (tyrosine kinase) mediates STAT signaling
through direct tyrosine phosphorylation of STAT proteins
followed by STAT dimerization. Down regulation of MPO,
an effector gene of neutrophil function is certainly indicative
of macrophage specific gene repression. The presence of
Nur77 in the category of LPS inducible genes (Figure 3) is
directly corresponding to previous reports in which the role
of NR4A orphan receptors (Nur77, Nurr1, Nor1) was
described as key regulators of chronic inflammatory diseases
thus in the innate immune response [26,27]. Taken together,
U937 cells serve a good model system with propensity of dif-
ferentiation and activation pathways intrinsic to primary
monocytes and macrophages.
Transcriptional regulators involved in macrophages 
differentiation and activation
Gene expression analysis of transcriptional regulators in
both U937 cells and primary macrophages revealed sev-
eral potentially novel factors. MEF2 family comprises 4
members (MEF2A, B, C, D) that are encoded by different
genes. They are described as key regulators in muscle cells
NM_004235 KLF4 1.5 1.7 -1 27 3.7 3 1.9
NM_002698 OCT2 2.1 3.3 -1.2 26 14.9 7 0.4
NM_030756 TCF7L2 3 2.8 -1.2 21 8.6 5.3 0.5
NM_004030 IRF7 2.2 2.6 -1.3 26 13 4.6 1.2
NM_014707 HDAC7 3.2 2.5 -1.2 22 29.9 16 0.7
NM_003884 PCAF 2 1.8 -1.2 25 3.7 1.4 0.8
NM_005919 MEF2B 1.3 1.4 1.3 27 6.5 0.4 0.8
58 genes representative of cytokines, chemokines, signaling molecules, transcription factors and histone modifiers were selected. NA (none 
applicable) denotes data not available from array experiment. *RQ = 2-ddCt in which ddCt = dCt(samples) - dCt(control U937 cells). dCt denotes Ct value 
normalized to GAPDH.
Table 2: Validation of array data by real-time PCR (Continued)Page 8 of 15
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[28]. Beside from T cell selection and function [29-31],
they are fairly unknown in the context of the immune sys-
tem. Previously, MEF2C was proved to be activated by
p38- mediated phosphorylation to induce transcription of
JUN which in turn regulates cytokine gene expression dur-
ing inflammatory response [32]. More recently, it has
been suggested that the MEF2 family is a versatile regula-
tor in diverse cellular systems [33-35]. However, no signif-
icant enrichment of MEF2 binding site was seen by
promoter analysis of differentially expressed genes (data
not shown). Possibly, not all MEF2 binding sites are yet
known to be available for complete analysis, thus prevent
the final conclusion. On the other hand, MEF2 might act
also through differential protein modification and indi-
rect binding to modulate gene expression. Specificity of
MEF2 and co-regulator complexes is likely to confer differ-
entiation and immune regulatory function in macro-
phages. Interestingly, HDAC5 and HDAC9, histone
deacetylases, known to form repression complexes with
MEF2 family members in many cellular systems are con-
comitantly up regulated. Both histone deacetylases belong
to class II histone deacetylase known to be involved in
phosphorylation dependent nucleo – cytoplasmic traf-
ficking in response to activation signals and the formation
of repression complexes [36-39]. During muscle develop-
ment, expression of MEF2 and HDAC9 was shown to be
increased during initial phase but diminished expression
of HDAC9 at late stage [40]. A likewise operation during
macrophage activation mechanism by which MEF2 up
regulates its own repressor HDAC9 can be suggested.
Among other factors up regulated in both U937 cells and
primary macrophages are HLX1 and BRI. HLX1 was
described as a marker of immature hematopoietic cells
and also known to be involved in the activation of T lym-
phocyte or NK cells [41,42]. BRI was identified as a LPS-
inducible gene in murine macrophages in the presence of
CSF-1 [43]. However, there has been no report correlating
expression and function of HLX1 and BRI in macro-
phages. Microarray demonstrated their constant up regu-
lation across different time points of PMA differentiation
(Table 2). Additionally, RT-PCR result shows constant up
regulation of BRI across LPS stimulation period in U937
cells (data not shown). Taken together, it can be strongly
suggested they play a role as effecter molecules of tran-
scriptional reprogramming in macrophages.
Inconsistent expression pattern and heterogeneity of 
transcription factors
There are several factors manifesting inconsistent expres-
sion patterns between U937 and primary cell systems.
TCF7L2 is one of them. On the contrary to PMA/U937
cells with which TCF7L2 induction of both mRNA and
protein were verified (Figure 5), M-CSF/macrophages
show no induction of TCF7L2 mRNA. Keeping in mind
that it is known as the hottest susceptibility gene for type
2 diabetes while being involved in glucose homeostasis,
individual heterogeneity of TCF7L2 expression observed
with M-CSF/macrophages in this study might be informa-
tive. During the past decade, many evidences pointed out
type 2 diabetes as a disease of innate immune system, par-
ticularly of macrophages, thus closely link the metabolic
syndrome to inflammatory pathway [44-46]. Such an
inter-relationship promises high probability of TCF7L2
Comparison of real time PCR result upon differentiation and activation betwe n primary monocytes a  U937 cellsFigure 4
Comparison of real time PCR result upon differentia-
tion and activation between primary monocytes and 
U937 cells. (Upper panel) Up regulation of CD11b alone 
but not of CD14 was observed with U937 cells differentiated 
with PMA. Prominent induction of TNFalpha after LPS stimu-
lation was seen with both cell types. (Lower panel) Up regu-
lation of CD14 and CD11b surely indicates maturation and 
activation of primary macrophages (M-CSF macrophages). 
Down regulation of TNFalpha upon macrophage differentia-
tion reflects intrinsic abundance of mRNA with in vivo mono-
cytes on the contrary to U937 cells. Mature macrophage 
stage was indicated by black bar (denoted as PMA/U937 cells 
or M-CSF macrophages). Activated macrophage stage was 
indicated by white bar (denoted as LPS). Error bars repre-
sent technical variation. RQ (relative quantification) = 2-ddCt.
140
-20
0
20
40
60
80
100
120
R
el
at
iv
e 
ex
p
re
ss
io
n
 (
R
Q
)
PMA/U937 cells
LPS
0
1
2
3
4
5
6
7
8
9
TNFa CD14 CD11b
R
el
at
iv
e 
ex
p
re
ss
io
n
 (
R
Q
) M-CSF macrophage
LPSPage 9 of 15
(page number not for citation purposes)
BMC Immunology 2009, 10:18 http://www.biomedcentral.com/1471-2172/10/18acting in macrophage biology. Another particularly inter-
esting example of inconsistency is up regulation of KLF2
observed with PMA/U937 cells on the contrary to M-CSF/
macrophages that shows down regulation. KLF2 was pre-
viously reported to be down regulated upon monocyte
differentiation or activation in THP-1 cells, and has been
proved to be a negative regulator of proinflammatory acti-
vation of monocytes [17]. The basis for this difference
between U937 and THP-1 cells may be due to the different
origin and maturation stage of cells. U937 cells are of tis-
sue origin (histocytic lymphoma) thus at more mature
stage. THP1 cells are of blood leukemic origin at less
mature stage. Importantly, up regulation rather than
down regulation of KLF2 did not produce the conse-
quences of abrogating inflammatory gene activation in
U937 cells. Based on the observation of Kumar and col-
leagues in which p65 and HDACs repress MEF2 transcrip-
tional activation of KLF2 promoter in endothelial cells, it
might be reasonable to assume that altered activity bal-
ance of antagonistic factors contribute to different cellular
activation [47]. The roles of KLF4 and IRF7 in the differen-
tiation or function of macrophages have been also
described previously [18,48,49], thus down regulation
rather than up regulation with primary macrophages
doesn't seem to be immediately accountable. One possi-
ble explanation is that an initial amount of protein avail-
able in different cell type determine up or down
regulation to adjust correct cellular dose. Another expla-
nation is that up regulation can be the effect of U937 cells
that are not equal to primary monocytes in the first place.
Taken together, the result emphasizes a necessary caution
to be exercised when interpreting data obtained from a
transformed cell line, alluding differential transcriptional
regulatory and signaling pathways between two systems.
Nevertheless, the heterogeneity of human individuals
observed with several factors (33%; n = 8) including ID3,
IRF9, IRF7, TCF7L2, HDAC7/9, OCT2, PCAF and MEF2B
raises a possibility that functional capacities of individual
macrophages might determine differential susceptibility
to and severity of various immune diseases. This enforce
the strong argument that investigations using primary
cells from different blood donors can greatly impede reli-
able conclusion of result, thus further emphasize the
necessity of a unified model system.
Table 3: Cross validation of 24 transcriptional regulators by real-time PCR
Ct ddCt Ct ddCt Ct ddCt
Ref.Seq gene Cont PMA24 LPS Mono* Macro* LPS* Mono* Macro* LPS*
NM_005587 MEF2A 19.1 -3.2 -2.1 25.2 -2.4 -3 ≥ 21.2 -1 -1.2
NM_002397 MEF2C 18.9 -3 -2.1 25.5 -2.8 -3 ≥ 19.8 -1.8 -1.8
NM_005920 MEF2D 25.5 -2.4 -1.6 26.4 -0.7 -1 ≈ 27.7 -0.8 -1.5
NM_021958 HLX1 22.6 -3.4 -1.8 24.7 -2.1 -2 ≈ 24.7 -2.2 -2.6
NM_021999 BRI 22.2 -3.1 -1.9 26 -2.9 -3 ≈ 18.9 -2 -2.8
NM_005474 HDAC5 23.7 -2.3 -2.2 26.8 -2 -2 ≈ 25.5 -1.8 -2
NM_012412 H2AV 18.6 -1.4 0.1 25.7 -1.1 -2 ≈ 19 -0.9 -1.3
NM_173158 Nur77 35 -0.2 -1.2 33.4 0 -2 ≈ 33.5 -1.7 -1.2
NM_001706 BCL6 24.6 -6.3 -5.1 27.8 0.3 -1 ≈ 20 -0.3 -1.3
NM_001964 EGR1 26.8 -3.9 -0.3 30.5 0.4 -5 ≥ 22.7 8.1 -2.7
NM_005252 FOS 25.5 -5 -1.4 23.7 2.8 -1 ≈ 21.6 2.7 -2
NM_002167 ID3 29.6 -3.7 -4.2 31 1.2 1.1 ≠ 23.5 -2.8 -2.3
NM_006084 IRF9 25.1 -4.5 -2.4 23.9 -1.6 -1 ≠ 21.9 0.3 -0.1
NM_000399 EGR2 28.2 -2.4 -2.1 27.7 2.6 0 ≤ 23.8 4.4 -0.7
NM_016270 KLF2 26.4 -5 -6.6 21.7 3 2.4 ≈ 16.7 5.1 3
NM_021784 FOXA2 29.5 -6.2 -3.7 30.2 3.3 2.2 ≈ 32.3 3 3
NM_005524 HES1 31.5 -4.8 -6 28 6.9 2.7 ≈ 21.5 11 9
NM_004235 KLF4 26.6 -3.9 -1.6 22 6.5 3.9 ≈ 20.3 4.9 4
NM_002698 OCT2 25.5 -3.9 -2.8 22.5 -0.5 -1 ≠ 19.4 0.8 1
NM_030756 TCF7L2 20.7 -3.1 -2.4 25 -0.4 0 ≠ 20.7 1.8 1
NM_004030 IRF7 26.4 -3.7 -2.2 25.3 0.1 -1 ≠ 23.9 1.6 1
NM_014707 HDAC7 22.2 -4.9 -4.2 27.8 1.4 1.1 ≠ 22.1 -0.3 -0.7
NM_003884 PCAF 25.1 -1.9 1.5 28.1 0.7 1.2 ≠ 28.4 -0.6 -0.9
NM_005919 MEF2B 27.3 -2.7 1.4 31.9 -0.3 0 ≠ 27.6 -0.5 -1.3
Primary cells
U937 cells donor 1 donor 2
* Primary monocytes were isolated from the blood of two healthy individuals designated as donor 1 and donor 2, differentiated by M-CSF into 
macrophages and stimulated by 10 μg/ml LPS. Degree of individual heterogeneity between two donors was expressed as nearly equal (≈), equal 
with different propensity (≥ or ≤), and opposite (≠).Page 10 of 15
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activation
Being surmised that increased expression of genes upon
differentiation may be already indicative of their serving
important roles in macrophage function afterward,
prompt induction of additional 278 genes within 2 hrs of
LPS stimulation is intriguing (Figure 2). It might have an
implication that promoters of these genes acquired poised
status ready to be quickly remodeled upon LPS signal.
Accordingly, increased expression of variant histone
H2AV, which is also known as H2AZ-2, suggests an excit-
ing possibility. As a dynamic regulator relying on its
deposit and loss, incorporation of H2AV in exchange with
H2A (canonical histone) could serve as a stable epigenetic
mark to keep quiescent promoters in a repressed state
while creating more permissive chromatin architecture
until appropriate activation signal is received [50-53].
Both forms of protein, H2AZ-1 (previously H2AZ) and
H2AZ-2 (previously H2AV), may play new or comple-
mentary functions [54]. There are probably several types
of chromatin remodeling in general. There may be a large
scale remodeling early in development and then more
regional remodeling as sections of chromatin become
active or are shut down. A more localized type of remod-
eling takes previously prepared regions and opens them
up completely upon receipt of more immediate signals for
active transcription. Each type may shares some protein
factors and also has unique factor involvement. It is
tempting to speculate that identified transcription factors
are operating to repress and induce target genes by direct-
ing decondensed chromatin structure (H2AV incorpora-
tion) during macrophage development which proceed
rapid nucleosome remodeling (H2AV eviction) upon LPS
stimulation [55]. One possible speculation is whether it
functions to activate or silence depend upon the nature of
the factors recruited to H2AZ containing nucleosomes
while turning off a set of genes and turning on a new sub-
set during the differentiation and inflammatory process.
Conclusion
Identification of novel transcriptional regulators
The focus of this study was the identification of transcrip-
tional regulators during macrophage differentiation and
activation using U937 cells as a model system. Several
novel transcription factors (i.e. MEF2 family, BRI, HLX1,
TCF7L2, ID3, NFIL3) were found to be up regulated in
addition to those already known (i.e. MAFB, EGR, BCL6,
IRF7, NFkB, JUN, FOS, STAT, Nur77) to be involved dur-
ing macrophage differentiation and/or inflammatory
response. We report for the first time both mRNA and pro-
tein induction of MEF2 proteins, a MADS-box transcrip-
tion factor family, during macrophage differentiation and
activation in U937 model system. In both U937 cells and
primary macrophage cells, three different isoforms of
MEF2 (MEF2A, 2C, 2D) appear to be concomitantly
induced, thus suggesting functional redundancy of differ-
ent members. Additionally, MEF2 is directly linking gene
activation with epigenetic gene regulation such as histone
acetylation and chromatin remodeling [3]. This hypothe-
sis is supported by the fact that interaction partners
known to modulate histone modification (HDAC 5 and
9) and chromatin structure (H2AV) are concomitantly
expressed.
Validity of U937 cells as a model system
U937 cells used in this study are proved to be very close to
functional monocytes as indicated by the low number of
differently expressed genes upon VitD3 differentiation,
thus can be an ideal model system to investigate gene reg-
ulatory mechanisms in differentiating macrophages. Array
Protein quantificationFigure 5
Protein quantification. Protein expression of NFkB1/p50, 
MEF2 and TCF7L2 is induced upon macrophage differentia-
tion and/or LPS stimulation, corresponding to mRNA 
expression. Prominent induction observed with p50 subunit 
upon LPS stimulation is in line with known classical role of 
NFkB1during macrophage activation. TCF7L2 protein was 
detected only in nucleic fraction. With MEF2 family of pro-
teins, decreasing expression of ca 55 kDa protein was 
observed (white bar) while nucleic fraction shows increasing 
expression of ca 60 kDa protein (black bar). The data are 
normalized to betaActin. Shown is the representative of two 
independent experiments.
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revealed a variety of genes intrinsic to macrophages,
inflammation and innate immunity. Nevertheless, how
faithfully do these cells resemble primary macrophages is
a question to be challenged with carefulness because dif-
ferentiation pathways in U937 cells-derived macrophages
and primary macrophages may diverges to some degree
considering the malignant origin of U937 cells. This was
asserted by cross validation of 24 transcriptional regula-
tors, which proved a 54.2% (n = 13) of tested factors with
consistent expression pattern between PMA differentiated
U937 cells and M-CSF differentiated monocytes. The
observed differences are based on different macrophage
maturation thus highlight the necessity of cross valida-
tion. Individual heterogeneity of blood donors further
emphasizes the advantage of using a unified model sys-
tem. Taken together, target genes under investigation
should be selected carefully keeping in mind that cells are
characterized by how they respond to various stimuli as
defined by gene expression. This allows PMA differenti-
ated U937 cells to act as representative of macrophages.
Future perspectives
As a next step, the role of new identified genes should be veri-
fied through functional studies such as RNAi knock down. A
further task would be to elucidate how newly identified tran-
scription regulators communicate with factors that modify
and remodel chromatin structure of target gene promoters.
Methods
U937 cell culture, differentiation, stimulation
U937 cells were maintained in RPMI 1640 medium (Gibco
BRL) supplemented with 10% FBS (Biochrome) under
humidified air with 5% CO2 at 37°C. Cell viability was esti-
mated regularly by trypan blue dye exclusion. To induce
differentiation into monocytes or adherent macrophages,
the cells were seeded at an initial density of 2 × 105 cells/ml
of VLE-RPMI (Biochrome) and cultured in the presence of
100 nM VitD3 (Calbiochem) or 10 nM PMA (Sigma) for up
to 48 hrs at 37°C. Differentiation was monitored by FACS
analysis for positive staining of cell surface markers, CD14
and CD11b. Briefly, control and differentiated cells were
collected, washed twice in PBS at 4°C, and incubated with
1 μg/ml anti-human FITC-conjugated anti-CD11b and PE-
conjugated anti-CD14 (Miltenyi Biotech. Inc.) for 10 min
at 4°C and washed once before being resuspended in FACS
buffer. For stimulation, differentiated cells were washed,
resuspended in VLE-RPMI and stimulated by adding 2 or
10 μg/ml of LPS (Sigma).
Generation of macrophages from primary blood 
monocytes
Human white blood cells were separated from blood buffy
coat of healthy donors by Ficoll-Paque density centrifuga-
tion. To isolate CD14+ monocytes, selection was performed
using immunomagnetic particles on AutoMACS (Miltenyi
Biotech, Germany) according to manufacturer's instruction.
Purity of monocyte suspension was confirmed by cell count-
ing (Sysmex-F 820, Germany), and only preparation proven
to have a level of contaminating platelets below the detec-
tion limit < 1 × 103/μl was selected. To generate monocyte
derived macrophages, 1 × 105 CD14+ cells were expanded in
96-well flat bottom plates containing 0.2 ml of RPMI 1640
medium with L-glutamine, 10% FCS (PAA laboratories, Aus-
tria) and 0.5% penicillin/streptomycin (10000 U/ml, Bayer,
Germany). As a differentiation inducer, 50 ng/ml macro-
phage-colony stimulating factor (M-CSF, Promokine, Ger-
many) was added and cells were cultured for 4 days at 37°C,
5% CO2 atmosphere. LPS stimulation was done at the final
concentration of 10 μg/ml.
RNA isolation, RT-PCR and real-time PCR
Total RNA was extracted from frozen cell pellet by using RNe-
asy Plus Mini kit (Qiagen) according to the manufacturer's
protocol. RNA concentration and purity was measured using
NanoDrop 1000A Spectrophotometer. 1 μg of total RNA from
each sample was reverse-transcribed to produce cDNA using
ImProm-II RT-system (Promega). SyBr-Green (ABgene) real-
time PCR was performed with ABI PRISM 7700 to generate
100 ~200 bps of product. All samples were run in duplicate or
triplicate and dissociation curve was generated after each run
to control formation of primer dimers. GAPDH or betaActin
was used as RNA loading control. Normalization of each data
point was carried out, in which dCt = Cttest gene - CtGAPDH; ddCt
= dCt(test sample) - dCt(U937 control). Primer sequences are listed in
Additional file 4.
cRNA Hybridization Array
To ensure quantitative accuracy and reproducibility of
expression analysis, two independent rounds of differen-
tiation and stimulation experiment were performed. For
each experiment, two biological replicates derived from
separate culture plates were run in parallel, and repre-
sented onto two separate BeadChip slides. Upon RNA iso-
lation and synthesis of labeled cRNA, an additional
sample was represented onto a separate slide thus satisfy-
ing a technical replicate. Prior to cRNA hybridization,
RNA integrity was evaluated by microfluidics analysis
using the Agilent 2100 bioanalyzer. cRNA synthesis and
labeling was performed using Illumina TotalPrep RNA
Amplification Kit (Ambion) then subsequently hybrid-
ized, according to the instruction of manufacturer, onto
Illumina Sentrix BeadChip Array, HumanRef-8 contain-
ing 24,000 features of oligonucleotide probe representing
majority of known human genes. Arrays were scanned
using Illumina BeadArray reader (V1.7.0.44). Our experi-
mental design adhered to MIAME (Minimum Informa-
tion About Microarray Experiments) guidelines.
Differential gene expression analysis
Raw data was acquired as signal intensity of each spot on
the array, and normalization was done by variance stabili-Page 12 of 15
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replicates were averaged beforehand. Differentially
expressed genes were determined based on a comparison of
normalized signal intensity ratio between experimental
(differentiated and/or stimulated U937 cells) and control
(undifferentiated U937 cells) samples, which was
expressed as fold change on a spread sheet tables.
Protein localization and quantification
Protein lysates were prepared using Cytosolic/Nucleic
fraction kit (BioCat), and concentrations were determined
by Bradford (BioRad) assay. 5 to 10 μg of proteins were
run on denaturing 10% polyacrylamide gel after 5 min
heating in Laemmli buffer, transferred onto polyvinyli-
dene fluoride (PDVF) membranes (Millipore). After
blocking in TBST with 1% BSA for one hour at RT, mem-
brane was incubated overnight at 4°C with primary anti-
bodies (1: 500 or 1: 1,000 dilution). Incubation with
horseradish peroxidase conjugated anti-rabbit secondary
AB (1: 2,000) was done for 1 hr (RT). Equal amount of
protein loading was confirmed by betaActin. After ECL
detection, signal intensity of specific band was analyzed
by AIDA image analysis program. The NFkB p50/105 pol-
yclonal (H-119) and MEF2 polyclonal antibodies (C-21)
were purchased from Santa Cruz Biotech. Monoclonal
antibody to TCF7L2 (C9B9, #2565) was from Cell Signal-
ling.
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